Skip to main content
. 2019 Aug 28;17:168. doi: 10.1186/s12916-019-1405-7

Table 4.

Summary of the results for the top 3 variants from the association testing

SNP Average infusion rate Resistant vs. sensitive Resistant vs. (sensitive + intermediate)
Phase I (N = 1205) Phase II (N = 329) Phase I (N = 589) Phase II (N = 147) Phase I (N = 1205) Phase II (N = 329)
β P β P OR P OR P OR P OR P
rs2069661 (F2RL2) 13.71 (7.81~19.6) 5.71E−06 14.32 (3.28~25.4) 0.012 3.50 (1.52~8.05) 3.19E−03 1.84 (0.26~13.18) 0.545 3.90 (1.97~7.70) 9.12E−05 2.28 (0.43~12.22) 0.335
 Sex − 4.05 (− 6.34~− 1.76) 5.44E−04 1.44 (− 2.87~5.74) 0.513 0.50 (0.33~0.75) 7.97E−04 0.59 (0.25~1.35) 0.210 0.71 (0.50~1.03) 0.068 1.00 (0.48~2.08) 0.995
 Age 0.08 (− 0.01~0.17) 0.078 0.16 (− 0.01~0.32) 0.065 0.97 (0.96~0.99) 2.58E−03 0.99 (0.95~1.02) 0.429 1.01 (0.99~1.02) 0.335 1.00 (0.97~1.03) 0.974
 Body weight 0.14 (0.09~0.19) 6.84E−08 0.18 (0.09~0.27) 1.19E−04 1.01 (1.00~1.02) 0.019 1.02 (0.99~1.04) 0.139 1.01 (1.01~1.02) 4.40E−04 1.01 (0.997~1.03) 0.112
 SNPxWeight 0.33 (0.08~0.57) 9.26E−03 0.05 (− 0.75~0.85) 0.895 1.01 (0.98~1.05) 0.512 1.04 (0.90~1.21) 0.581 1.02 (0.99~1.06) 0.172 1.02 (0.91~1.15) 0.695
rs77080086 (PDE4B) 12.17 (7.43~16.91) 5.50E−07 6.43 (− 3.32~16.2) 0.197 1.40 (0.69~2.8) 0.35 1.59 (0.33~7.57) 0.562 1.75 (0.93~3.30) 0.082 1.7 (0.40~7.21) 0.468
 Sex − 3.81 (− 6.09~− 1.53) 1.08E−03 1.10 (− 3.24~5.45) 0.620 0.51 (0.34~0.77) 1.09E−03 0.55 (0.24~1.26) 0.155 0.74 (0.51~1.06) 0.098 0.95 (0.46~1.97) 0.899
 Age 0.07 (− 0.02~0.02) 0.115 0.16 (− 0.01~0.33) 0.060 0.97 (0.96~0.99) 2.20E−03 0.99 (0.95~1.02) 0.459 1.01 (0.99~1.02) 0.387 1.00 (0.97~1.03) 0.943
 Body weight 0.14 (0.09~0.19) 5.69E−08 0.18 (0.09~0.27) 8.74E−05 1.01 (1.00~1.02) 0.016 1.02 (0.996~1.04) 0.125 1.01 (1.01~1.02) 4.42E−04 1.01 (0.998~1.03) 0.096
 SNPxWeight − 0.05 (− 0.26~0.17) 0.679 0.36 (− 0.40~1.11) 0.354 0.99 (0.96~1.02) 0.641 0.99 (0.90~1.09) 0.832 1.00 (0.98~1.03) 0.953 1.00 (0.91~1.11) 0.995
rs11572377 (EDN2) 12.26 (6.32~18.2) 5.44E−05 15.14 (5.08~25.19) 3.41E−03 3.95 (1.30~11.97) 0.015 5.97 (1.35~26.32) 0.018 2.03 (0.97~4.25) 0.047 4.3 (1.28~14.63) 0.018
 Sex − 4.05 (− 6.32~− 1.78) 4.86E−04 0.88 (− 3.40~5.17) 0.687 0.52 (0.35~0.78) 1.72E−03 0.54 (0.23~1.26) 0.151 0.72 (0.50~1.04) 0.079 0.9 (0.45~1.94) 0.848
 Age 0.078 (− 0.01~0.17) 0.086 0.17 (0.01~0.03) 0.038 0.97 (0.96~0.99) 4.42E−03 1.00 (0.96~1.02) 0.526 1.01 (0.99~1.02) 0.335 1.0 (0.97~1.03) 0.862
 Body weight 0.13 (0.08~0.18) 3.28E−07 0.18 (0.09~0.27) 1.32E−04 1.01 (1.00~1.02) 0.021 1.02 (0.998~1.04) 0.068 1.01 (1.01~1.02) 7.83E−04 1.0 (0.997~1.03) 0.110
 SNPxWeight 0.01 (− 0.22~0.24) 0.96 − 0.26 (− 0.61~0.10) 0.155 1.05 (0.97~1.12) 0.219 0.97 (0.88~1.06) 0.479 1.01 (0.98~1.03) 0.613 0.96 (0.91~1.01) 0.120

The effect sizes for SNP, sex, age, and body weight were the main effect size in linear or logistic regression models for the quantitative or categorical traits respectively. The effect size of SNP × Weight was the effects of the interaction terms in the models which include only the SNP, body weight, and their interaction. Regression β and odds ratio (OR) were presented as mean (95% confidence interval)